J&J reportedly in talks to buy Protagonist (JNJ:NYSE)

Protagonist Therapeutics (NASDAQ:PTGX), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall Street Journal reported that Johnson & Johnson (NYSE:JNJ) is in talks to acquire the company. Citing people familiar with the matter, the publication noted ...